uniQure NV (QURE)
5.78
-0.06
(-1.11%)
USD |
NASDAQ |
Nov 22, 16:00
5.775
0.00 (0.00%)
Pre-Market: 20:00
uniQure Gross Profit Margin (Quarterly): 55.36% for Sept. 30, 2024
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 55.36% |
| June 30, 2024 | 32.94% |
| March 31, 2024 | -8.73% |
| December 31, 2023 | -32.08% |
| September 30, 2023 | 28.50% |
| June 30, 2023 | 44.18% |
| March 31, 2023 | 54.27% |
| December 31, 2022 | 98.39% |
| September 30, 2022 | 40.58% |
| June 30, 2022 | -67.40% |
| March 31, 2022 | |
| December 31, 2021 | 96.88% |
| September 30, 2021 | |
| June 30, 2021 | 95.00% |
| March 31, 2021 | |
| December 31, 2020 | |
| September 30, 2020 | |
| June 30, 2020 | |
| March 31, 2020 | |
| December 31, 2019 | |
| September 30, 2019 | |
| June 30, 2019 | |
| March 31, 2019 |
| Date | Value |
|---|---|
| December 31, 2018 | |
| September 30, 2018 | |
| June 30, 2018 | |
| March 31, 2018 | |
| December 31, 2017 | |
| September 30, 2017 | |
| June 30, 2017 | |
| March 31, 2017 | |
| December 31, 2016 | |
| September 30, 2016 | |
| June 30, 2016 | |
| March 31, 2016 | |
| December 31, 2015 | |
| September 30, 2015 | 86.41% |
| June 30, 2015 | |
| March 31, 2015 | |
| December 31, 2014 | |
| September 30, 2014 | |
| June 30, 2014 | |
| March 31, 2014 | |
| December 31, 2013 | 98.06% |
| September 30, 2013 | |
| June 30, 2013 | -5.54% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
-67.40%
Minimum
Jun 2022
98.39%
Maximum
Dec 2022
36.49%
Average
42.38%
Median
Gross Profit Margin (Quarterly) Benchmarks
| ProQR Therapeutics NV | -- |
| Merus NV | -- |
| argenx SE | 89.70% |
| Pharming Group | 90.89% |
| Pharvaris NV | -- |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Equity | -154.3% |
| Return on Assets | -31.10% |
| Return on Invested Capital | -96.96% |
| Profit Margin (Quarterly) | -1.94K% |
| Operating Margin (Quarterly) | -1.76K% |
| Return on Net Operating Assets | -133.9% |